state-of-the-art treatment for hr-mds
Published 3 years ago • 55 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:16
state of the art: mds
-
1:06
the current state of the art in hr-mds and the need to improve treatment approaches
-
7:05
state-of-the-art treatment regimens for lr-mds
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
2:16
current and future treatment approaches for hr-mds
-
2:16
the current state-of-the-art in mf and pv therapy and future outlooks
-
2:38
how to treat difficult forms of mds
-
3:21
an insight into the standard of care in hr-mds and future outlooks
-
7:54
patient/caregiver stories - living with mds
-
6:36
mds: low-risk disease treatment options
-
4:48
managing and treating mds
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
3:08
the treatment protocol for higher risk mds
-
1:17
the curative potential of allosct in the treatment of hr-mds
-
2:43
novel therapies in the future of mds treatment
-
1:41
an overview of the mds diagnosis pathway
-
1:04
the future of mds management
-
2:18
new targets for mds treatment
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:20
the current standard of care for patients with lower-risk mds
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
4:08
personalization of care for mds patients